We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$3.74B
AUM Growth
-$335M
Cap. Flow
-$614M
Cap. Flow %
-16.42%
Top 10 Hldgs %
21.69%
Holding
674
New
53
Increased
215
Reduced
238
Closed
121

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$107M
2
AAPL icon
Apple
AAPL
+$71.8M
3
TRV icon
Travelers Companies
TRV
+$27.6M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$27.4M
5
AXP icon
American Express
AXP
+$26.9M

Sector Composition

Rank Sector Weight
1 Healthcare 28.7%
2 Financials 10.88%
3 Technology 9.76%
4 Communication Services 9.34%
5 Consumer Staples 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ITCI
126
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$7.33M 0.2%
136,200
+20,000
+17% +$1.01M
DG icon
127
Dollar General
DG
$25.9B
$7.15M 0.19%
99,515
-134,617
-57% -$9.13M
VLO icon
128
Valero Energy
VLO
$89.8B
$7.05M 0.19%
99,666
+8,481
+9% +$578K
OLN icon
129
Olin
OLN
$2.64B
$7.04M 0.19%
408,000
-102,000
-20% -$1.96M
AAP icon
130
Advance Auto Parts
AAP
$3.37B
$6.98M 0.19%
+46,392
New +$8.06M
HAS icon
131
Hasbro
HAS
$12.6B
$6.9M 0.18%
102,378
+31,541
+45% +$2.31M
PAYX icon
132
Paychex
PAYX
$40.4B
$6.89M 0.18%
130,313
+91,736
+238% +$4.8M
TAL icon
133
TAL Education Group
TAL
$5.71B
$6.83M 0.18%
+882,000
New +$6.01M
LXFT
134
DELISTED
Luxoft Holding, Inc.
LXFT
$6.81M 0.18%
88,260
-68,060
-44% -$4.93M
CA
135
DELISTED
CA, Inc.
CA
$6.76M 0.18%
236,865
+126,860
+115% +$3.56M
KGC icon
136
Kinross Gold
KGC
$28.5B
$6.71M 0.18%
3,713,852
+3,688,912
+14,791% +$7.29M
PBYI icon
137
Puma Biotechnology
PBYI
$406M
$6.61M 0.18%
84,300
+24,000
+40% +$1.88M
EMC
138
DELISTED
EMC CORPORATION
EMC
$6.61M 0.18%
257,188
-523,227
-67% -$13.6M
TWC
139
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
$6.59M 0.18%
35,531
-652
-2% -$121K
NBIX icon
140
Neurocrine Biosciences
NBIX
$17.7B
$6.34M 0.17%
112,000
+21,000
+23% +$1.07M
PVH icon
141
PVH
PVH
$3.71B
$6.28M 0.17%
85,273
+74,998
+730% +$6.63M
IP icon
142
International Paper
IP
$22.3B
$6.28M 0.17%
175,779
-77,213
-31% -$2.97M
IONS icon
143
Ionis Pharmaceuticals
IONS
$9.35B
$6.22M 0.17%
100,485
+4,800
+5% +$259K
D icon
144
Dominion Energy
D
$62.5B
$6.15M 0.16%
90,941
+74,310
+447% +$5.13M
GIB icon
145
CGI
GIB
$13.9B
$5.89M 0.16%
+147,573
New +$5.87M
HON icon
146
Honeywell
HON
$77.1B
$5.88M 0.16%
63,236
-459
-0.7% -$42.1K
DISCK
147
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$5.86M 0.16%
232,253
+96,563
+71% +$2.64M
XLRN
148
DELISTED
Acceleron Pharma
XLRN
$5.85M 0.16%
120,000
+19,200
+19% +$691K
CPGX
149
DELISTED
COLUMBIA PIPELINE GROUP IN COM STK (DE)
CPGX
$5.84M 0.16%
292,087
+218,130
+295% +$4.32M
HP icon
150
Helmerich & Payne
HP
$3.53B
$5.8M 0.16%
108,363
+6,981
+7% +$386K

Similar funds

Candriam SCA's Q4 2015 Portfolio in Review

As of Q4 2015, Candriam SCA held 674 positions worth $3.74B, down 8.2% from $4.07B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA withdrew a net $614M in Q4 2015, closing 121 positions and reducing 238 holdings. Its most notable exit was Amgen, an estimated $107M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 29% a quarter earlier, followed by Financials and Technology.

Against the trend, Candriam SCA opened a new position in Alphabet (Google) Class A worth $118M.

  • Candriam SCA's largest Q4 2015 buy was Alphabet (Google) Class A: 3,043,280 shares worth $118M.
  • Candriam SCA added most to Intel in Q4 2015, an estimated $61.2M increase.
  • Candriam SCA's biggest Q4 2015 reduction was Colgate-Palmolive, cutting an estimated $21.3M.
  • Candriam SCA fully exited Amgen in Q4 2015, selling an estimated $107M.
  • Candriam SCA's ten largest holdings make up 22% of its $3.74B portfolio in Q4 2015.
  • Candriam SCA opened 53 new positions and closed 121 in Q4 2015.
  • Candriam SCA's portfolio value fell 8.2% quarter-over-quarter to $3.74B.

Based on Candriam SCA's 13F filing for Q4 2015, filed 25 Jan 2016.